• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适用于小儿肝移植受者的改良肝供体风险指数。

A modified liver donor risk index for pediatric liver transplant recipients.

作者信息

Guhan Maya, Montgomery Ashley, Varghese Ron, Rana Abbas

机构信息

Baylor College of Medicine, Houston, Texas, USA.

Baylor University, Waco, Texas, USA.

出版信息

Liver Transpl. 2024 Mar 1;30(3):262-268. doi: 10.1097/LVT.0000000000000293. Epub 2023 Oct 30.

DOI:10.1097/LVT.0000000000000293
PMID:37903063
Abstract

The liver donor risk index (LDRI) was developed by Feng et al to predict the quality of donor liver allografts. However, there is currently no literature documenting the application and efficacy of Feng's LDRI specifically for the pediatric population. The goal of our study is to apply Feng's LDRI to our study population as well as develop a pediatric-specific LDRI. De-identified data from the United Network for Organ Sharing for 7836 recipients with pediatric transplant were retrospectively analyzed from January 1, 2000, to July 1, 2022. We performed a univariate and multivariate Cox regression analysis to determine the significant recipient and transplant factors impacting pediatric liver allograft survival. These significant factors were used to construct the pediatric-specific LDRI index. Receiver operator characteristic curve analysis was utilized to compare the pediatric-specific and Feng LDRI indexes at 1, 5, and 10 years.​​ Our pediatric-specific LDRI includes 4 variables found to be significant in pediatric populations: donor age: 35-50, ≥ 50; cold ischemia time ≤ 6, and aspartate aminotransferase level > 1000. In addition, our pediatric-specific LDRI had a higher receiver operator characteristic c -statistic compared to Feng's LDRI at 1 year (0.57 vs. 0.55), 5 years (0.57 vs. 0.50), and 10 years (0.58 vs. 0.47). Our findings indicate that there is a need to create a pediatric-specific LDRI as the Feng LDRI has not been shown to be efficacious in pediatric populations. Our index may serve as a starting point for the development of a comprehensive pediatric LDRI.

摘要

肝脏供体风险指数(LDRI)由冯等人开发,用于预测供体肝脏同种异体移植的质量。然而,目前尚无文献记录冯氏LDRI在儿科人群中的应用及疗效。我们研究的目的是将冯氏LDRI应用于我们的研究人群,并开发一个针对儿科的LDRI。对2000年1月1日至2022年7月1日器官共享联合网络中7836例接受儿科移植受者的去识别数据进行回顾性分析。我们进行了单因素和多因素Cox回归分析,以确定影响儿科肝脏同种异体移植存活的显著受者和移植因素。这些显著因素被用于构建针对儿科的LDRI指数。采用受试者工作特征曲线分析,比较针对儿科的LDRI指数和冯氏LDRI指数在1年、5年和10年时的情况。我们针对儿科的LDRI包括在儿科人群中发现具有显著意义的4个变量:供体年龄:35 - 50岁、≥50岁;冷缺血时间≤6小时,以及天冬氨酸转氨酶水平>1000。此外,我们针对儿科的LDRI在1年时(0.57对0.55)、5年时(0.57对0.50)和1年时(0.58对0.47)的受试者工作特征曲线c统计量高于冯氏LDRI。我们的研究结果表明,由于冯氏LDRI在儿科人群中未显示出有效性,因此需要创建一个针对儿科的LDRI。我们的指数可作为开发全面儿科LDRI的起点。

相似文献

1
A modified liver donor risk index for pediatric liver transplant recipients.适用于小儿肝移植受者的改良肝供体风险指数。
Liver Transpl. 2024 Mar 1;30(3):262-268. doi: 10.1097/LVT.0000000000000293. Epub 2023 Oct 30.
2
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
3
Donor History of Drug Use and Graft Survival in Pediatric Heart Transplant Recipients.小儿心脏移植受者的供体药物使用史与移植物存活情况
JAMA Netw Open. 2025 Apr 1;8(4):e257766. doi: 10.1001/jamanetworkopen.2025.7766.
4
Clinical outcomes of kidney transplantation from expanded-criteria donors and KDPI>85% kidneys in deceased Chinese donors.中国已故供者中扩大标准供者及肾脏疾病综合诊断指数(KDPI)>85%的肾脏进行肾移植的临床结局
BMC Nephrol. 2025 Jul 11;26(1):377. doi: 10.1186/s12882-025-04307-9.
5
[Efficacy and prognostic factors of split liver transplantation from pediatric donors].[小儿供体劈离式肝移植的疗效及预后因素]
Zhonghua Yi Xue Za Zhi. 2025 Jun 24;105(24):1997-2004. doi: 10.3760/cma.j.cn112137-20250206-00255.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Do Patients of Different Levels of Affluence Receive Different Care for Pediatric Osteosarcomas? One Institution's Experience.不同富裕程度的患者在小儿骨肉瘤治疗上是否得到不同的护理?一家机构的经验。
Clin Orthop Relat Res. 2025 Apr 1;483(4):748-758. doi: 10.1097/CORR.0000000000003299. Epub 2024 Oct 30.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.提高实体器官移植受者免疫抑制剂药物依从性的干预措施。
Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2.
10
Normothermic and hypothermic machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.常温及低温机器灌注保存与静态冷藏在尸体供肾移植中的比较。
Cochrane Database Syst Rev. 2024 Jul 9;7(7):CD011671. doi: 10.1002/14651858.CD011671.pub3.